Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;70(7):2232-2238.
doi: 10.4103/ijo.IJO_322_22.

Rare eye diseases in India: A concise review of genes and genetics

Affiliations
Review

Rare eye diseases in India: A concise review of genes and genetics

Nallathambi Jeyabalan et al. Indian J Ophthalmol. 2022 Jul.

Abstract

Rare eye diseases (REDs) are mostly progressive and are the leading cause of irreversible blindness. The disease onset can vary from early childhood to late adulthood. A high rate of consanguinity contributes to India's predisposition to RED. Most gene variations causing REDs are monogenic and, in some cases, digenic. All three types of Mendelian inheritance have been reported in REDs. Some of the REDs are related to systemic illness with variable phenotypes in affected family members. Approximately, 50% of the children affected by REDs show associated phenotypes at the early stages of the disease. A precise clinical diagnosis becomes challenging due to high clinical and genetic heterogeneity. Technological advances, such as next-generation sequencing (NGS), have improved genetic and genomic testing for REDs, thereby aiding in determining the underlying causative gene variants. It is noteworthy that genetic testing together with genetic counseling facilitates a more personalized approach in the accurate diagnosis and management of the disease. In this review, we discuss REDs identified in the Indian population and their underlying genetic etiology.

Keywords: Genetic analysis; genetic counseling; next-generation sequencing; rare eye diseases.

PubMed Disclaimer

Conflict of interest statement

None

References

    1. Neethirajan G, Hanson IM, Krishnadas SR, Vijayalakshmi P, Anupkumar K, Sundaresan P. A novel PAX6 gene mutation in an Indian aniridia patient. Mol Vis. 2003;9:205–9. - PubMed
    1. Jordan T, Hanson I, Zaletayev D, Hodgson S, Prosser J, Seawright A, et al. The human PAX6 gene is mutated in two patients with aniridia. Nat Genet. 1992;1:328–32. - PubMed
    1. Crolla JA, van Heyningen V. Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia. Am J Hum Genet. 2002;71:1138–49. - PMC - PubMed
    1. Nishina S, Kohsaka S, Yamaguchi Y, Handa H, Kawakami A, Fujisawa H, et al. PAX6 expression in the developing human eye. Br J Ophthalmol. 1999;83:723–7. - PMC - PubMed
    1. Nallathambi J, Neethirajan G, Shashikant S, Vijayalakshmi P, Sundaresan P. PAX6 missense mutations associated in patients with optic nerve malformation. Mol Vis. 2006;12:236–42. - PubMed